Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Notices 52683 

for the Subcommittee on Procedures 

Reviews (SPR) of the Advisory Board on 

Radiation and Worker Health (ABRWH 

or the Advisory Board). This meeting is 

open to the public, but without a public 

comment period. The public is welcome 

to submit written comments in advance 

of the meeting, to the contact person 

below. Written comments received in 

advance of the meeting will be included 

in the official record of the meeting. The 

public is also welcomed to listen to the 

meeting by joining the audio conference 

(information below). The audio 

conference line has 150 ports for callers. 

DATES: The meeting will be held on 

November 3, 2021, from 11:00 a.m. to 

3:30 p.m., EDT. The public may submit 

written comments from September 22, 

2021 through October 27, 2021. 

ADDRESSES: You may submit comments 

by mail to: Sherri Diana, National 

Institute for Occupational Safety and 

Health, 1090 Tusculum Avenue, MS C– 

34, Cincinnati, Ohio 45226. Meeting 

Information: Audio Conference Call via 

FTS Conferencing. The USA toll-free 

dial-in number is 1–866–659–0537; the 

pass code is 9933701. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, NIOSH, CDC, 1090 

Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone: 

(513) 533–6800, Toll Free 1(800)CDC– 

INFO, Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction, which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program; and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the Advisory 

Board to HHS, which subsequently 

delegated this authority to CDC. NIOSH 

implements this responsibility for CDC. 

The Advisory Board’s charter was 

issued on August 3, 2001, renewed at 

appropriate intervals, and rechartered 

under Executive Order 13889 on March 

22, 2020, and will terminate on March 

22, 2022. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. SPR 

is responsible for overseeing, tracking, 

and participating in the reviews of all 

procedures used in the dose 

reconstruction process by the NIOSH 

Division of Compensation Analysis and 

Support (DCAS) and its dose 

reconstruction contractor (Oak Ridge 

Associated Universities—ORAU). 

Matters To Be Considered: The agenda 

will include discussions on the 

following dose reconstruction 

procedures: (a) Procedures associated 

specifically with the following sites: 

Grand Junction Facilities, Aluminum 

Company of America, General Steel 

Industries; Clarksville and Medina 

Modification Centers, (b) procedures 

associated with Atomic Weapons 

Employers generally; and (c) general 

procedures for dose reconstructions. 

Agenda items are subject to change as 

priorities dictate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–20477 Filed 9–21–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0098] 

Advisory Committee on Immunization 

Practices (ACIP) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. The meeting will be webcast 

live via the World Wide Web; for more 

information on ACIP please visit the 

ACIP website: http://www.cdc.gov/ 

vaccines/acip/index.html. 

DATES: The meeting will be held on 

October 20–21, 2021, from 10:00 a.m. to 

5:00 p.m., EDT (times subject to 

change). The public may submit written 

comments from September 22, 2021 

through October 21, 2021. 

ADDRESSES: You may submit comments 

identified by Docket No. CDC–2021– 

0098 by any of the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

MS H24–8, Atlanta, Georgia 30329– 

4027, Attn: ACIP Meeting. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

Written public comments submitted 

up to 72 hours prior to the ACIP 

meeting will be provided to ACIP 

members before the meeting. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, MS–H24–8, Atlanta, Georgia 30329– 

4027; Telephone: (404) 639–8367; 

Email: ACIP@cdc.gov. 

52684 Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Notices 

SUPPLEMENTARY INFORMATION: 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children program, along 

with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the CDC Director and 

appear on CDC immunization schedules 

must be covered by applicable health 

plans. 

Matters To Be Considered: The agenda 

will include discussions on adult 

immunization schedule, child/ 

adolescent immunization schedule, 

Ebola vaccine, hepatitis vaccines, 

herpes zoster vaccines, Orthopoxviruses 

vaccine, influenza vaccines, 

pneumococcal vaccine, cholera vaccine 

and tickborne encephalitis vaccine. 

Recommendation votes on adult 

immunization schedule, child/ 

adolescent immunization schedule, 

hepatitis vaccine, herpes zoster vaccine, 

Orthopoxviruses vaccine, pneumococcal 

vaccine and Ebola vaccine are 

scheduled. No Vaccines for Children 

votes are scheduled. Agenda items are 

subject to change as priorities dictate. 

For more information on the meeting 

agenda visit https://www.cdc.gov/ 

vaccines/acip/meetings/meetingsinfo.html. 

Meeting Information: The meeting 

will be webcast live via the World Wide 

Web; for more information on ACIP 

please visit the ACIP website: http://

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on October 1, 2021. Written 

comments must be received on or before 

October 21, 2021. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes including all votes 

relevant to the ACIP’s Affordable Care 

Act and Vaccines for Children Program 

roles. Priority will be given to 

individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedures 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the October 20–21, 

2021 ACIP meeting must submit a 

request at http://www.cdc.gov/vaccines/ 

acip/meetings/ no later than 11:59 p.m., 

EDT, October 18, 2021, according to the 

instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by October 19, 2021. To accommodate 

the significant interest in participation 

in the oral public comment session of 

ACIP meetings, each speaker will be 

limited to 3 minutes, and each speaker 

may only speak once per meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–20476 Filed 9–21–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0089] 

Advisory Committee on Immunization 

Practices (ACIP); Correction Notice of 

Meeting 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. The meeting will be webcast 

live via the World Wide Web; for more 

information on ACIP please visit the 

ACIP website: http://www.cdc.gov/ 

vaccines/acip/index.html. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given of a change in the meeting 

of the Advisory Committee on 

Immunization Practices (ACIP); August 

30, 2021, 10:00 a.m. to 4:00 p.m., and 

August 31, 2021, 10:00 a.m. to 4:00 

p.m., EDT (times subject to change), in 

the amended FRN. 

The virtual meeting was published in 

the Federal Register on Thursday, 

August 26, 2021, Volume 86, Number 

163, pages 47644–47645. 

The virtual meeting is being corrected 

to change the dates and times, addresses 

and written public comment and should 

read as follows: 

DATES: The meeting will be held on 

August 30, 2021, from 10:00 a.m. to 4:00 

p.m., EDT (times subject to change). The 

docket will close on August 30, 2021. 

Written comments must be received on 

or before August 30, 2021. 

A notice of this ACIP meeting has also 

been posted on CDC’s ACIP website at: 

http://www.cdc.gov/vaccines/acip/ 

index.html. In addition, CDC has sent 

notice of this ACIP meeting by email to 

those who subscribe to receive email 

updates about ACIP. The meeting is 

open to the public. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0089 by any of the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

MS H24–8, Atlanta, Georgia 30329–